We are live on ! Find out more
NWBO

Northwest Biotherapeutics, Inc. Common stock
NWBO

Delisted

NWBO was delisted on the 16th of December, 2016.

Back to rankings

8 hedge funds and large institutions have $83.3K invested in Northwest Biotherapeutics, Inc. Common stock in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$41.3K
2
+$2.21K
3
+$124

Top Sellers

1
-$2K
2
-$413
Name Holding Trade Value Shares
Change 		Change in
Stake
KFA
1
Kelleher Financial Advisors
New York
$41.3K
VWA
2
VSM Wealth Advisory
Maryland
$16.6K
OCG
3
Opus Capital Group
Ohio
$12K
EFG
4
Ethos Financial Group
Pennsylvania
$8.07K
WJWM
5
Williams Jones Wealth Management
New York
$5.16K
ME
6
McIlrath & Eck
Washington
$124
AMG
7
Advisors Management Group
Wisconsin
–